Related Experiment Video

Updated: Aug 13, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Differentiating agents and nontoxic therapies

C E Myers1

  • 1Department of Medicine, University of Virginia School of Medicine, Charlottesville, USA.

The Urologic Clinics of North America
|June 11, 1999
PubMed

Insights

New anticancer drugs target genetic changes driving cancer. Suramin blocks malignant transformation loops, while fatty acids and other agents like vitamin D show promise for cancer therapy with low toxicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Understanding oncogenes and genetic mutations driving malignant transformation opens new avenues for cancer drug development.
  • Autocrine loops are critical mechanisms in malignant transformation, presenting a target for therapeutic intervention.

Purpose of the Study:

  • To review novel anticancer agents and their mechanisms of action, focusing on those targeting genetic alterations and cellular processes.
  • To highlight drugs like Suramin that block autocrine loops and other agents with potential for low-toxicity cancer treatment.

Main Methods:

  • Review of scientific literature on oncogenes, malignant transformation, and emerging anticancer agents.
  • Analysis of drug mechanisms, including Suramin's blockade of autocrine loops and the role of fatty acids.

Main Results:

  • Suramin is identified as the first drug to inhibit malignant transformation by blocking autocrine loops.
  • Phenylacetate and related compounds induce differentiation in normal and malignant cells.
  • Arachidonic acid influences prostate cancer progression, with its effects modifiable by diet and pharmacology.

Conclusions:

  • Targeting oncogenic pathways and cellular differentiation offers promising strategies for cancer therapy.
  • A range of agents, including Suramin, fatty acids, vitamin D analogs, isoflavones, green tea polyphenols, and retinoic acid analogs, show potential for effective and low-toxicity cancer treatment.

More Related Videos

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...